A risk-reducing strategy has brought Cephalon success but now brings the firm face to face with a new set of risks. By Deborah Erickson Risk, like the poor, is always with us. Founded in 1987 as a the
Proteomics is hot; genomics is not. We interview the top players to understand how they're dealing with the climatic change. by Roger Longman Biotechnology is a world of continuously changing scientif
Instead of trying to imagine the biological world through genetic shadows, a host of new companies want researchers and physicians to see it in its proteomic reality. by Roger Longman In the last nine
Building a Structural Genomics Platform In bacteria, one gene usually produces a single protein. But in humans, a given gene usually encodes for six to ten, and in some cases up to 20 different protei